Cargando…
Stem cells: a new paradigm for disease modeling and developing therapies for age-related macular degeneration
Age-related macular degeneration (AMD) is the leading cause of blindness in people over age 55 in the U.S. and the developed world. This condition leads to the progressive impairment of central visual acuity. There are significant limitations in the understanding of disease progression in AMD as wel...
Autores principales: | Melville, Heather, Carpiniello, Matthew, Hollis, Kia, Staffaroni, Andrew, Golestaneh, Nady |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599723/ https://www.ncbi.nlm.nih.gov/pubmed/23452406 http://dx.doi.org/10.1186/1479-5876-11-53 |
Ejemplares similares
-
Dysregulated metabolic pathways in age-related macular degeneration
por: Zhang, Meng, et al.
Publicado: (2020) -
Dysfunctional autophagy in RPE, a contributing factor in age-related macular degeneration
por: Golestaneh, Nady, et al.
Publicado: (2017) -
Pgc-1α repression and high-fat diet induce age-related macular degeneration-like phenotypes in mice
por: Zhang, Meng, et al.
Publicado: (2018) -
Age-Related Macular Degeneration: New Paradigms for Treatment and Management of AMD
por: Hernández-Zimbrón, Luis Fernando, et al.
Publicado: (2018) -
Repressed SIRT1/PGC-1α pathway and mitochondrial disintegration in iPSC-derived RPE disease model of age-related macular degeneration
por: Golestaneh, Nady, et al.
Publicado: (2016)